Delivery Order SPE2DB20D1004-SPE2DB23FF9F4
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,545.35 Firm Fixed Price delivery order is for the supply of 12,000 unit capsules of the pharmaceutical product CREON DR. The award has an ultimate completion date of December 19, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of 24,000 unit capsules of the medication CREON DR. The $5,323.90 fixed-price contract has a completion date of May 6, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $10,154.70 firm fixed-price delivery order contract is for the supply of 36,000 units of the drug product CREON DR 100S capsules. The contract has an ultimate completion date of February 12, 2024 and was awarded on February 9, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $8,212.95 firm-fixed-price contract is for the delivery of 36,000 unit capsules of the pharmaceutical product CREON DR 100S. The award has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $13,200.39 firm fixed price delivery order is for 36,000 units of the drug CREON DR 100S capsules. This award is associated with Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,640.57 firm-fixed-price delivery order is for the supply of 36,000 units of CREON DR 250S capsules. This contract award is a part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order (SPE2DB23FU33S) issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $5,014.57 firm-fixed-price contract is for the delivery of 36,000 unit capsules of CREON DR 100S, a pharmaceutical product. The contract has an ultimate completion date of July 12, 2023. Amerisourcebergen, a major pharmaceutical distributor, holds a significant $999,999,999 Indefinite Delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 24,000 units of Creon DR 100s capsules. The $1,225.41 firm fixed-price delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between the DLA Troop Support Medical and Amerisourcebergen's parent company, Cencora, Inc. This IDC serves as a primary vehicle for Cencora to supply a comprehensive range of...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $14,387.89 for the supply of 24,000 units of the pharmaceutical product Creon DR Capsule. The contract was awarded on September 27, 2021, with a completion date of September 28, 2021, and was placed by the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract is a firm-fixed-price delivery order, without any set-aside designation,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $5,636.52 Firm Fixed Price delivery order provides 36,000 units of 100-count capsules of the pharmaceutical product Creon DR. The contract has an ultimate completion date of January 24, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- SPE2DB20D1004Indefinite Delivery Contract
- SPE2DB20D1004-SPE2DB23FF9F4Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $5,192.39 firm fixed-price delivery order is for 36,000 units of the pharmaceutical product CREON DR 36,000 UNIT CAPSULE 100S. The award has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical commodities. These IDCs enable efficient government procurement of essential pharmaceuticals and medical supplies for military personnel, veterans, and other federal beneficiaries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.2k | 5/22/23 |